Retraction: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease

Retraction: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease

Bibliographic Details
Main Authors:	Wang Gang, Li Biao, Lu Guo-Qiang, Wang Xi-Jing, Liu Wei-Guo, Chen Sheng-Di
Format:	Article
Language:	English
Published:	BMC 2009-11-01
Series:	Molecular Neurodegeneration
Online Access:	http://www.molecularneurodegeneration.com/content/4/1/45

Similar Items

Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
by: Wang Gang, et al.
Published: (2007-10-01)

Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion.
by: David Reyes-Corona, et al.
Published: (2017-01-01)

Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease
by: Pia Runeberg-Roos, et al.
Published: (2016-12-01)

Overexpression of Suppressors of Cytokine Signaling 1 Promotes the Neuronal Differentiation of C17.2 Neural Stem Cells
by: Meng Cui, et al.
Published: (2014-02-01)

Créditos 17.2
by: Créditos 17.2
Published: (2012-11-01)

Intraputamenal Infusion of Exogenous Neurturin Protein Restores Motor and Dopaminergic Function in the Globus Pallidus of MPTP-Lesioned Rhesus Monkeys
by: R. Grondin Ph.D., et al.
Published: (2008-04-01)

The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease.
by: Gokhan Akkoyunlu, et al.
Published: (2010-11-01)

Retraction: Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and Neurturin In Vitro: Potential therapeutic application for Parkinson's disease in a rhesus monkey model.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats.
by: PLOS ONE Editors
Published: (2021-01-01)

Effects of IGFBP-2 on proliferation and differentiation in neural stem cell line C17.2
by: Deng Y, et al.
Published: (2017-07-01)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
by: Shane V Hegarty, et al.
Published: (2017-01-01)

Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease
by: Jose A. Botella, et al.
Published: (2008-04-01)

Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease.
by: Xingli Deng, et al.
Published: (2013-01-01)

Effect of crude venom from the spider Chilobrachys jingzhao on the proliferation and differentiation of C17.2 neural stem cells
by: Wenying Li, et al.
Published: (2018-09-01)

AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson’s disease
by: Mehdi Gasmi, et al.
Published: (2007-07-01)

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.
by: Min Yan, et al.
Published: (2013-01-01)

A mechanistic study of Toxoplasma gondii ROP18 inhibiting differentiation of C17.2 neural stem cells
by: Xian Zhang, et al.
Published: (2017-11-01)

The CsHSP17.2 molecular chaperone is essential for thermotolerance in Camellia sinensis
by: Mingle Wang, et al.
Published: (2017-04-01)

Neurturin Evokes MAPK-Dependent Upregulation of Egr4 and KCC2 in Developing Neurons
by: Anastasia Ludwig, et al.
Published: (2011-01-01)

Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease
by: Raymond T. Bartus, et al.
Published: (2011-10-01)

Valsartan Reduced Atrial Fibrillation Susceptibility by Inhibiting Atrial Parasympathetic Remodeling through MAPKs/Neurturin Pathway
by: Lei Liu, et al.
Published: (2015-07-01)

Dopaminergic agonists in Parkinson's disease
by: A. Alonso Cánovas, et al.
Published: (2014-05-01)

FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]
by: Xu C, et al.
Published: (2017-05-01)

GDF11 induces differentiation and apoptosis and inhibits migration of C17.2 neural stem cells via modulating MAPK signaling pathway
by: Zongkui Wang, et al.
Published: (2018-09-01)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
by: Aracil-Bolaños, I., et al.
Published: (2021)

Berberine Protects C17.2 Neural Stem Cells From Oxidative Damage Followed by Inducing Neuronal Differentiation
by: Jia-Wen Shou, et al.
Published: (2019-09-01)

Neurturin enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat
by: Klein Robert D, et al.
Published: (2007-03-01)

Maintenance and neuronal cell differentiation of neural stem cells C17.2 correlated to medium availability sets design criteria in microfluidic systems.
by: Bu Wang, et al.
Published: (2014-01-01)

DOPAMINERGIC AND NON-DOPAMINERGIC MECHANISMS OF NON-MOTOR SYMPTOMS OF PARKINSON DISEASE
by: Titus Mihai Vasile, et al.
Published: (2012-12-01)

Study the regeneration of dopaminergic neurons in zebrafish
by: Yu Chien Liu, et al.
Published: (2019)

Retracted: Overexpression of NTRK1 Promotes Differentiation of Neural Stem Cells into Cholinergic Neurons
by: BioMed Research International
Published: (2019-01-01)

Mechanisms of Dopaminergic Neurodegeneration in Parkinson's Disease
by: Verma, Aditi
Published: (2018)

Non-Dopaminergic Systems in Parkinson's Disease
Published: (2020)

Fasudil Stimulates Neurite Outgrowth and Promotes Differentiation in C17.2 Neural Stem Cells by Modulating Notch Signalling but not Autophagy
by: Shu Chen, et al.
Published: (2015-05-01)

Neurturin Gene Therapy Protects Parasympathetic Function to Prevent Irradiation-Induced Murine Salivary Gland Hypofunction
by: Joao N.A. Ferreira, et al.
Published: (2018-06-01)

Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies
by: R.T. Bartus, et al.
Published: (2015-06-01)

Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson's disease.
by: Yue Wang, et al.
Published: (2013-01-01)

¬Mesenchymal Stem Cell Fate: Applying Biomaterials for Control of Stem Cell Behaviour
by: Hilary Jane Anderson, et al.
Published: (2016-05-01)

Reconstruction of Dopaminergic neurons Metabolic Network with Application to Parkinson's Disease
by: Chao-Min Wang, et al.
Published: (2015)

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson’s Disease
by: Yanqin Wang, et al.
Published: (2017-01-01)

Cannot write session to /tmp/vufind_sessions/sess_i1b6sb3hd53mrid7p6686dtf47